Skip to main content
FinSpry Logo
FinSpry
TVRD logo
TVRD
(NASDAQ)
Tvardi Therapeutics, Inc.
$2.56-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Tvardi Therapeutics (TVRD) Stock Price & Financial Analysis

Tvardi Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.52 - $2.74
52-Week High$43.65
52-Week Low$1.50
Open$2.69
Volume491.36K
Average Volume (3M)4.51M
Market Cap24.01M
Shares Outstanding9.38M
Price to Sales (P/S)9.35
Price to Book (P/B)1.15
EV/EBITDA-0.12
Revenue (TTM)2.57M
Net Income (TTM)-15.91M
Free Cash Flow (TTM)-24.49M
EPS (TTM)$-1.74
Profit Margin-619.31%
Operating Margin-1167.03%
Return on Equity (ROE)-75.96%
Debt to Equity0.01
50-Day MA$3.01
200-Day MA$4.70
52-Week Change-91.06%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Tvardi Therapeutics

What is the current stock price for TVRD?

As of the latest trading session, TVRD stock trades at $2.56. The 52-week range is $1.50–$43.65, with a day range of $2.52–$2.74.

What is the P/E ratio for TVRD?

The P/E ratio (Price-to-Earnings) for TVRD is shown in the Key Statistics section. This valuation metric helps compare Tvardi Therapeutics, Inc. to industry peers.

Does TVRD pay dividends?

Tvardi Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TVRD?

Based on 7 analysts, the consensus for TVRD is Buy.

What is the market cap of TVRD?

Tvardi Therapeutics's market capitalization is $24.0M, classifying it as a micro-cap company. Tvardi Therapeutics operates in the Healthcare sector within the Biotechnology industry.